Neuphoria Therapeutics (NEUP) Tax Rate (2023 - 2026)

Neuphoria Therapeutics (NEUP) has reported Tax Rate for 4 consecutive years, with 6.44% the latest figure, recorded in Q1 2026.

• On a quarterly basis, Tax Rate rose 717.0% year-over-year to 6.44% in Q1 2026; TTM through Mar 2026 was 1.54%, a 7386.0% increase from a year earlier, with the FY2025 full-year figure at 6.59%, down 1841.0% from the prior year.
• Tax Rate was 6.44% for Q1 2026 at Neuphoria Therapeutics, up from 1.9% in the prior quarter.
• Over five years, Tax Rate peaked at 141.18% in Q2 2024 and troughed at 1.9% in Q4 2025.
• A 4-year average of 14.67% and a median of 0.63% in 2023 frame the typical range for Tax Rate.
• Across the five-year window, Tax Rate surged 1348 bps in 2024 and tumbled 13945 bps in 2025, its largest moves.
• Over 4 years, Tax Rate stood at 0.76% in 2023, then sank by 179 bps to 0.6% in 2024, then sank by 217 bps to 1.9% in 2025, then surged by 439 bps to 6.44% in 2026.
• The last three Tax Rate figures came in at 6.44% (Q1 2026), 1.9% (Q4 2025), and 0.35% (Q3 2025), per Business Quant data.